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Abstract: Citation indexes represent helpful tools for evaluating the impact of articles on research.
The aim of this study was to obtain the top-100 ranking of the most cited papers on melatonin, a
relevant neurohormone mainly involved in phase-adjusting the biological clock and with certain
sleep-promoting capability. An article search was carried out on the Institute for Scientific Information
(ISI) Web of Science platform. Numbers of citations, names of authors, journals and their 2014-impact
factor, year of publication, and experimental designs of studies were recorded. The ranking of
the 100-most cited articles on melatonin research (up to February 2016) revealed a citation range from
1623 to 310. Narrative reviews/expert opinions were the most frequently cited articles, while the
main research topics were oxidative stress, sleep physiology, reproduction, circadian rhythms and
melatonin receptors. This study represents the first detailed analysis of the 100 top-cited articles
published in the field of melatonin research, showing its impact and relevance in the biomedical field.
Keywords: bibliometrics; biological clock; circadian rhythms; endocrinology; sleep
1. Introduction
By simply typing the word “melatonin” on the PubMed database, more than 1000 records can be
easily retrieved, for just year 2015. Melatonin, the main sleep-promoting neurohormone involved in
phase-adjusting the circadian clockworks upon prior phase-shifting, recently received overpowering
attention in science, medicine and social media, and it is expected to gain even more attention within
the near future.
Such a feeling is strongly supported by analyzing the “citation index” of this molecule, i.e. how
many times researchers have cited papers on melatonin over time. “Citation index” is, to date, one of
the most reliable methods for assessing the quality and the “scientific power” of a paper, a journal or
an issue [1], reflecting its impact on research, opening further discussion, producing changes in clinical
practice, starting controversy inside scientific community and providing new perspectives in science
and in financial funding as well.
The top-100 rank of the highly cited papers provides an interesting picture of the current “hot”
topics, even delineating those trends expected to further explode in the future. Along this direction,
the rankings of the 100 top-cited articles have been published in a plethora of biomedical disciplines,
such as emergency medicine [2], cardiology [3], orthopedic surgery [4] and dentistry [5]. Considering
the wide and increasing interest on this hormone, this work aims to provide and analyze the ranking
of the 100 top-cited articles on melatonin research.
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2. Results
During our search we excluded only one article for being out-of-topic, namely a review by Del
Rio et al. on the toxic molecule malondialdehyde as a biological marker of oxidative stress [6]. We
found that the number of citations in the top-100 rank (Table 1), ranged between 1623 and 310; each
of the first five articles exceeded 1000 citations and the first sixty articles had more than 400 citations.
These findings provide the major, pivotal hint of the huge impact of melatonin in science, since all
papers of our ranking had more than 100 citations, the latter considered the threshold to identify a
“classic” article [7,8]—the “last” article, at position 100, had 310 citations. This also suggests that due
to the nature of this ranking, a very large number of classics have not been here included, despite their
undeniable scientific importance.
Table 1. Top-100 rank of the most cited articles in the field of melatonin research.
Ranking Article Citations
1 Valko, M.; Morris, H.; Cronin, M.T.D. Metals, toxicity and oxidative stress.Curr. Med. Chem. 2005, 12, 1161–1208 [9]. 1623
2 Reiter, R.J. Pineal melatonin: Cell biology of its synthesis and of its physiologicalinteractions. Endocr. Rev. 1991, 12, 151–180 [10]. 1572
3
Tan, D.-X.; Chen, L.D.; Poeggeler, B.; Manchester, L.C.; Reiter, R.J.; others.
Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocr. J. 1993, 1,
57–60 [11].
1420
4 Reiter, R.J. The pineal and its hormones in the control of reproduction inmammals. Endocr. Rev. 1980, 1, 109–131 [12]. 1219
5 Lewy, A.J.; Wehr, T.A.; Goodwin, F.K.; Newsome, D.A.; Markey, S.P. Lightsuppresses melatonin secretion in humans. Science 1980, 210, 1267–1269 [13]. 1105
6 Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress, andantioxidants: A review. J. Biochem. Mol. Toxicol. 2003, 17, 24–38 [14]. 975
7
Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolín, I.; Herrera, F.; Martín, V.;
Reiter, R.J. Regulation of antioxidant enzymes: A significant role for melatonin.
J. Pineal Res. 2004, 36, 1–9 [15].
886
8
Lerner, A.B.; Case, J.D.; Takahashi, Y.; Lee, T.H.; Mori, W. Isolation of melatonin,
the pineal gland factor that lightens melanocytes. J. Am. Chem. Soc. 1958, 80,
2587–2587 [16].
836
9 Axelrod, J. The pineal gland: A neurochemical transducer. Science 1974, 184,1341–1348 [17]. 815
10 Brzezinski, A. Melatonin in humans. N. Engl. J. Med. 1997, 336, 186–195 [18]. 802
11
Reppert, S.M.; Weaver, D.R.; Ebisawa, T. Cloning and characterization of a
mammalian melatonin receptor that mediates reproductive and circadian
responses. Neuron 1994, 13, 1177–1185 [19].
802
12 Klein, D.C.; Weller, J.L. Indole metabolism in the pineal gland: A circadianrhythm in N-acetyltransferase. Science 1970, 169, 1093–1095 [20]. 757
13
Ancoli-Israel, S.; Cole, R.; Alessi, C.; Chambers, M.; Moorcroft, W.; Pollak, C.P.




Tan, D.-X.; Manchester, L.C.; Terron, M.P.; Flores, L.J.; Reiter, R.J. One molecule,
many derivatives: A never-ending interaction of melatonin with reactive oxygen
and nitrogen species? J. Pineal Res. 2007, 42, 28–42 [22].
765
15
Toh, K.L.; Jones, C.R.; He, Y.; Eide, E.J.; Hinz, W.A.; Virshup, D.M.; Ptácek, L.J.;
Fu, Y.H. An hPer2 phosphorylation site mutation in familial advanced sleep
phase syndrome. Science 2001, 291, 1040–1043 [23].
716
16
Rollag, M.D.; Niswender, G.D. Radioimmunoassay of serum concentrations of
melatonin in sheep exposed to different lighting regimens. Endocrinology 1976,
98, 482–489 [24].
688
17 Reiter, R.J. Oxidative processes and antioxidative defense mechanisms in theaging brain. FASEB J 1995, 9, 526–533 [25]. 678
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Table 1. Cont.
Ranking Article Citations
18 Reiter, R.J. Oxidative damage in the central nervous system: Protection bymelatonin. Prog. Neurobiol. 1998, 56, 359–384 [26]. 668
19 Reiter, R.J.; Tan, D.X.; Osuna, C.; Gitto, E. Actions of melatonin in the reductionof oxidative stress. A review. J. Biomed. Sci. 2000, 7, 444–458 [27]. 665
20
Reiter, R.J.; Melchiorri, D.; Sewerynek, E.; Poeggeler, B.; Barlow-Walden, L.;
Chuang, J.; Ortiz, G.G.; Acuña-Castroviejo, D. A review of the evidence
supporting melatonin’s role as an antioxidant. J. Pineal Res. 1995, 18, 1–11 [28].
663
21 Reiter, R.J. The melatonin rhythm: Both a clock and a calendar. Experientia 1993,49, 654–664 [29]. 660
22
Reppert, S.M.; Godson, C.; Mahle, C.D.; Weaver, D.R.; Slaugenhaupt, S.A.;
Gusella, J.F. Molecular characterization of a second melatonin receptor expressed
in human retina and brain: The Mel1b melatonin receptor. Proc. Natl. Acad. Sci.
USA 1995, 92, 8734–8738 [30].
641
23
Czeisler, C.A.; Duffy, J.F.; Shanahan, T.L.; Brown, E.N.; Mitchell, J.F.; Rimmer,
D.W.; Ronda, J.M.; Silva, E.J.; Allan, J.S.; Emens, J.S.; Dijk, D.J.; Kronauer, R.E.
Stability, precision, and near-24-hour period of the human circadian pacemaker.
Science 1999, 284, 2177–2181 [31].
607
24
Brainard, G.C.; Hanifin, J.P.; Greeson, J.M.; Byrne, B.; Glickman, G.; Gerner, E.;
Rollag, M.D. Action spectrum for melatonin regulation in humans: Evidence for
a novel circadian photoreceptor. J. Neurosci. 2001, 21, 6405–6412 [32].
582
25 Tamarkin, L.; Baird, C.J.; Almeida, O.F. Melatonin: A coordinating signal formammalian reproduction? Science 1985, 227, 714–720 [33]. 573
26 Lincoln, G.A.; Short, R.V. Seasonal breeding: Nature’s contraceptive. Recent Prog.Horm. Res. 1980, 36, 1–52 [34]. 562
27 Fraser, S.; Cowen, P.; Franklin, M.; Franey, C.; Arendt, J. Directradioimmunoassay for melatonin in plasma. Clin. Chem. 1983, 29, 396–397 [35]. 554
28
Tan, D.; Reiter, R.J.; Manchester, L.C.; Yan, M.; El-Sawi, M.; Sainz, R.M.; Mayo,
J.C.; Kohen, R.; Allegra, M.; Hardeland, R. Chemical and physical properties and
potential mechanisms: melatonin as a broad spectrum antioxidant and free
radical scavenger. Curr. Top. Med. Chem. 2002, 2, 181–197 [36].
539
29
Karsch, F.J.; Bittman, E.L.; Foster, D.L.; Goodman, R.L.; Legan, S.J.; Robinson, J.E.
Neuroendocrine basis of seasonal reproduction. Recent Prog. Horm. Res. 1984, 40,
185–232 [37].
527
30 Cao, G.; Prior, R.L. Comparison of different analytical methods for assessingtotal antioxidant capacity of human serum. Clin. Chem. 1998, 44, 1309–1315 [38]. 516
31 Provencio, I.; Rodriguez, I.R.; Jiang, G.; Hayes, W.P.; Moreira, E.F.; Rollag, M.D. Anovel human opsin in the inner retina. J. Neurosci. 2000, 20, 600–605 [39]. 514
32
Schernhammer, E.S.; Laden, F.; Speizer, F.E.; Willett, W.C.; Hunter, D.J.; Kawachi,
I.; Colditz, G.A. Rotating night shifts and risk of breast cancer in women
participating in the nurses’ health study. J. Natl. Cancer Inst. 2001, 93,
1563–1568 [40].
514
33 Lewy, A.J.; Sack, R.L.; Miller, L.S.; Hoban, T.M. Antidepressant and circadianphase-shifting effects of light. Science 1987, 235, 352–354 [41]. 511
34
Morgan, P.J.; Barrett, P.; Howell, H.E.; Helliwell, R. Melatonin receptors:
Localization, molecular pharmacology and physiological significance.
Neurochem. Int. 1994, 24, 101–146 [42].
498
35 Kidd, P. Th1/Th2 balance: the hypothesis, its limitations, and implications forhealth and disease. Altern. Med. Rev. J. Clin. Ther. 2003, 8, 223–246 [43]. 495
36
Sun, Z.S.; Albrecht, U.; Zhuchenko, O.; Bailey, J.; Eichele, G.; Lee, C.C. RIGUI, a
putative mammalian ortholog of the Drosophila period gene. Cell 1997, 90,
1003–1011 [44].
494
37 Tosini, G.; Menaker, M. Circadian rhythms in cultured mammalian retina. Science1996, 272, 419–421 [45]. 488
38
Allegra, M.; Reiter, R.J.; Tan, D.-X.; Gentile, C.; Tesoriere, L.; Livrea, M.A. The
chemistry of melatonin’s interaction with reactive species. J. Pineal Res. 2003, 34,
1–10 [46].
479




Ascher, J.A.; Cole, J.O.; Colin, J.N.; Feighner, J.P.; Ferris, R.M.; Fibiger, H.C.;
Golden, R.N.; Martin, P.; Potter, W.Z.; Richelson, E. Bupropion: A review of its
mechanism of antidepressant activity. J. Clin. Psychiatry 1995, 56, 395–401 [47].
478
40
Lewy, A.J.; Ahmed, S.; Jackson, J.M.; Sack, R.L. Melatonin shifts human circadian




Tamarkin, L.; Westrom, W.K.; Hamill, A.I.; Goldman, B.D. Effect of melatonin on
the reproductive systems of male and female Syrian hamsters: A diurnal rhythm
in sensitivity to melatonin. Endocrinology 1976, 99, 1534–1541 [49].
457
42
Liu, C.; Weaver, D.R.; Jin, X.; Shearman, L.P.; Pieschl, R.L.; Gribkoff, V.K.;
Reppert, S.M. Molecular dissection of two distinct actions of melatonin on the
suprachiasmatic circadian clock. Neuron 1997, 19, 91–102 [50].
446
43 Redman, J.; Armstrong, S.; Ng, K.T. Free-running activity rhythms in the rat:Entrainment by melatonin. Science 1983, 219, 1089–1091 [51]. 441
44 Maestroni, G.J. The immunoneuroendocrine role of melatonin. J. Pineal Res. 1993,14, 1–10 [52]. 439
45
Dollins, A.B.; Zhdanova, I.V.; Wurtman, R.J.; Lynch, H.J.; Deng, M.H. Effect of
inducing nocturnal serum melatonin concentrations in daytime on sleep, mood,




Thapan, K.; Arendt, J.; Skene, D.J. An action spectrum for melatonin suppression:
evidence for a novel non-rod, non-cone photoreceptor system in humans.
J. Physiol. 2001, 535, 261–267 [54].
431
47 Nicholls, T.J.; Goldsmith, A.R.; Dawson, A. Photorefractoriness in birds andcomparison with mammals. Physiol. Rev. 1988, 68, 133–176 [55]. 427
48
Goldman, B.D. Mammalian photoperiodic system: Formal properties and
neuroendocrine mechanisms of photoperiodic time measurement. J. Biol.
Rhythms 2001, 16, 283–301 [56].
425
49 Davis, S.; Mirick, D.K.; Stevens, R.G. Night shift work, light at night, and risk ofbreast cancer. J. Natl. Cancer Inst. 2001, 93, 1557–1562 [57]. 422
50 Reiter, R.; Tang, L.; Garcia, J.J.; Muñoz-Hoyos, A. Pharmacological actions ofmelatonin in oxygen radical pathophysiology. Life Sci. 1997, 60, 2255–2271 [58]. 422
51
Axelrod, J.; Wurtman, R.J.; Snyder, S.H. Control of hydroxyindole
o-methyltransferase activity in the rat pineal gland by environmental lighting.
J. Biol. Chem. 1965, 240, 949–954 [59].
420
52 Grohmann, U.; Fallarino, F.; Puccetti, P. Tolerance, DCs and tryptophan: Muchado about IDO. Trends Immunol. 2003, 24, 242–248 [60]. 419
53
Reiter, R.J.; Tan, D.X.; Manchester, L.C.; Qi, W. Biochemical reactivity of
melatonin with reactive oxygen and nitrogen species: a review of the evidence.
Cell Biochem. Biophys. 2001, 34, 237–256 [61].
418
54
Barlow-Walden, L.R.; Reiter, R.J.; Abe, M.; Pablos, M.; Menendez-Pelaez, A.;
Chen, L.D.; Poeggeler, B. Melatonin stimulates brain glutathione peroxidase
activity. Neurochem. Int. 1995, 26, 497–502 [62].
415
55
Pieri, C.; Marra, M.; Moroni, F.; Recchioni, R.; Marcheselli, F. Melatonin: A
peroxyl radical scavenger more effective than vitamin E. Life Sci. 1994, 55,
PL271–276 [63].
414
56 Reppert, S.M.; Weaver, D.R.; Rivkees, S.A.; Stopa, E.G. Putative melatoninreceptors in a human biological clock. Science 1988, 242, 78–81 [64]. 413
57 Kamberi, I.A.; Mical, R.S.; Porter, J.C. Effects of melatonin and serotonin on therelease of FSH and prolactin. Endocrinology 1971, 88, 1288–1293 [65]. 409
58 Pardridge, W.M. Transport of protein-bound hormones into tissues in vivo.Endocr. Rev. 1981, 2, 103–123 [66]. 407
59
Sugden, D.; Vanecek, J.; Klein, D.C.; et al. Activation of protein kinase C
potentiates isoprenaline-induced cyclic AMP accumulation in rat pinealocytes.
Nature 1985, 314, 359–361 [67].
406
60 Dawson, A.; King, V.M.; Bentley, G.E.; Ball, G.F. Photoperiodic control ofseasonality in birds. J. Biol. Rhythms 2001, 16, 365–380 [68]. 401
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Ranking Article Citations
61 Dubocovich, M.L. Melatonin is a potent modulator of dopamine release in theretina. Nature 1983, 306, 782–784 [69]. 399
62 Wurtman, R.J.; Axelrod, J.; Phillips, L.S. Melatonin synthesis in the pineal gland:control by light. Science 1963, 142, 1071–1073 [70]. 392
63
Bartness, T.J.; Powers, J.B.; Hastings, M.H.; Bittman, E.L.; Goldman, B.D. The
timed infusion paradigm for melatonin delivery: What has it taught us about the
melatonin signal, its reception, and the photoperiodic control of seasonal
responses? J. Pineal Res. 1993, 15, 161–190 [71].
394
64
Klein, D.C.; Coon, S.L.; Roseboom, P.H.; Weller, J.L.; Bernard, M.; Gastel, J.A.;
Zatz, M.; Iuvone, P.M.; Rodriguez, I.R.; Bégay, V.; et al. The melatonin
rhythm-generating enzyme: molecular regulation of serotonin
N-acetyltransferase in the pineal gland. Recent Prog. Horm. Res. 1997, 52, 307–357;
discussion 357–358 [72].
391
65 Vanecek, J. Cellular mechanisms of melatonin action. Physiol. Rev. 1998, 78,687–721 [73] 389
66
Carter, D.S.; Goldman, B.D. Antigonadal effects of timed melatonin infusion in
pinealectomized male Djungarian hamsters (Phodopus sungorus sungorus):
Duration is the critical parameter. Endocrinology 1983, 113, 1261–1267 [74].
385
67
Zeitzer, J.M.; Dijk, D.J.; Kronauer, R.; Brown, E.; Czeisler, C. Sensitivity of the
human circadian pacemaker to nocturnal light: Melatonin phase resetting and
suppression. J. Physiol. 2000, 526 (Pt 3), 695–702 [75].
385
68 Vaneˇcek, J.; Pavlík, A.; Illnerová, H. Hypothalamic melatonin receptor sitesrevealed by autoradiography. Brain Res. 1987, 435, 359–362 [76]. 368
69
Hill, S.M.; Blask, D.E. Effects of the pineal hormone melatonin on the
proliferation and morphological characteristics of human breast cancer cells
(MCF-7) in culture. Cancer Res. 1988, 48, 6121–6126 [77].
363
70
Kamberi, I.A.; Mical, R.S.; Porter, J.C. Effect of anterior pituitary perfusion and
intraventricular injection of catecholamines and indoleamines on LH release.
Endocrinology 1970, 87, 1–12 [78].
360
71
Pandi-Perumal, S.R.; Srinivasan, V.; Maestroni, G.J. M.; Cardinali, D.P.; Poeggeler,
B.; Hardeland, R. Melatonin: Nature’s most versatile biological signal? FEBS J.
2006, 273, 2813–2838 [79].
376
72 Galano, A.; Tan, D.X.; Reiter, R.J. Melatonin as a natural ally against oxidativestress: A physicochemical examination. J. Pineal Res. 2011, 51, 1–16 [80]. 399
73
Bromage, N.; Porter, M.; Randall, C. The environmental regulation of maturation
in farmed finfish with special reference to the role of photoperiod and melatonin.
Aquaculture 2001, 197, 63–98 [81].
368
74
Poeggeler, B.; Reiter, R.J.; Tan, D.X.; Chen, L.D.; Manchester, L.C. Melatonin,
hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J. Pineal
Res. 1993, 14, 151–168 [82].
362
75 Jezek, P.; Hlavatá, L. Mitochondria in homeostasis of reactive oxygen species incell, tissues, and organism. Int. J. Biochem. Cell Biol. 2005, 37, 2478–2503 [83]. 356
76
Ebisawa, T.; Karne, S.; Lerner, M.R.; Reppert, S.M. Expression cloning of a
high-affinity melatonin receptor from Xenopus dermal melanophores. Proc. Natl.
Acad. Sci. USA 1994, 91, 6133–6137 [84].
353
77
Stehle, J.H.; Foulkes, N.S.; Molina, C.A.; Simonneaux, V.; Pévet, P.; Sassone-Corsi,
P. Adrenergic signals direct rhythmic expression of transcriptional repressor
CREM in the pineal gland. Nature 1993, 365, 314–320 [85].
353
78 Dubocovich, M.L. Melatonin receptors: are there multiple subtypes? TrendsPharmacol. Sci. 1995, 16, 50–56 [86]. 350
79
Antolín, I.; Rodríguez, C.; Saínz, R.M.; Mayo, J.C.; Uría, H.; Kotler, M.L.;
Rodríguez-Colunga, M.J.; Tolivia, D.; Menéndez-Peláez, A. Neurohormone
melatonin prevents cell damage: effect on gene expression for antioxidant
enzymes. FASEB J. 1996, 10, 882–890 [87].
349
80 Cassone, V.M. Effects of melatonin on vertebrate circadian systems. TrendsNeurosci. 1990, 13, 457–464 [88]. 346
81
Prokopenko, I.; Langenberg, C.; Florez, J.C.; Saxena, R.; Soranzo, N.; Thorleifsson,
G.; Loos, R.J.F.; Manning, A.K.; Jackson, A.U.; Aulchenko, Y.; et al. Variants in
MTNR1B influence fasting glucose levels. Nat. Genet. 2009, 41, 77–81 [89].
346




Czeisler, C.A.; Shanahan, T.L.; Klerman, E.B.; Martens, H.; Brotman, D.J.; Emens,
J.S.; Klein, T.; Rizzo, J.F. Suppression of melatonin secretion in some blind
patients by exposure to bright light. N. Engl. J. Med. 1995, 332, 6–11 [90].
345
83 Walther, D.J.; Bader, M. A unique central tryptophan hydroxylase isoform.Biochem. Pharmacol. 2003, 66, 1673–1680 [91]. 345
84 Suntres, Z.E. Role of antioxidants in paraquat toxicity. Toxicology 2002, 180,65–77 [92]. 344
85
Nemecek, G.M.; Coughlin, S.R.; Handley, D.A.; Moskowitz, M.A. Stimulation of
aortic smooth muscle cell mitogenesis by serotonin. Proc. Natl. Acad. Sci. USA
1986, 83, 674–678 [93].
338
86
Schernhammer, E.S.; Laden, F.; Speizer, F.E.; Willett, W.C.; Hunter, D.J.; Kawachi,
I.; Fuchs, C.S.; Colditz, G.A. Night-shift work and risk of colorectal cancer in the
nurses’ health study. J. Natl. Cancer Inst. 2003, 95, 825–828 [94].
338
87
Ruby, N.F.; Brennan, T.J.; Xie, X.; Cao, V.; Franken, P.; Heller, H.C.; O’Hara, B.F.




Simonneaux, V.; Ribelayga, C. Generation of the melatonin endocrine message in
mammals: A review of the complex regulation of melatonin synthesis by




Reppert, S.M.; Weaver, D.R.; Godson, C. Melatonin receptors step into the light:
cloning and classification of subtypes. Trends Pharmacol. Sci. 1996, 17,
100–102 [97].
325
90 Wurtman, R.J.; Axelrod, J.; Chu, E.W. Melatonin, a Pineal Substance: Effect onthe Rat Ovary. Science 1963, 141, 277–278 [98]. 324
91 Kopin, I.J.; Pare, C.M.; Axelrod, J.; Weissbach, H. The fate of melatonin inanimals. J. Biol. Chem. 1961, 236, 3072–3075 [99]. 323
92 Bubenik, G.A. Gastrointestinal melatonin: Localization, function, and clinicalrelevance. Dig. Dis. Sci. 2002, 47, 2336–2348 [100]. 323
93 Lerner, A.B.; Case, J.D.; Heinzelman, R.V. Structure of melatonin. J. Am. Chem.Soc. 1959, 81, 6084–6085 [101]. 320
94
Hoffmann, K. The influence of photoperiod and melatonin on testis size, body
weight, and pelage colour in the Djungarian hamster (Phodopus sungorus).
J. Comp. Physiol. 1973, 85, 267–282 [102].
316
95
Maestroni, G.J.; Conti, A.; Pierpaoli, W. Role of the pineal gland in immunity.
Circadian synthesis and release of melatonin modulates the antibody response
and antagonizes the immunosuppressive effect of corticosterone.
J. Neuroimmunol. 1986, 13, 19–30 [103].
314
96
Garfinkel, D.; Laudon, M.; Nof, D.; Zisapel, N. Improvement of sleep quality in
elderly people by controlled-release melatonin. Lancet Lond. Engl. 1995, 346,
541–544 [104].
314
97 Nelson, R.J.; Demas, G.E. Seasonal changes in immune function. Q. Rev. Biol.1996, 71, 511–548 [105]. 314
98
Weaver, D.R.; Rivkees, S.A.; Reppert, S.M. Localization and characterization of
melatonin receptors in rodent brain by in vitro autoradiography. J. Neurosci.
1989, 9, 2581–2590 [106].
312
99
Tan, D.X.; Manchester, L.C.; Reiter, R.J.; Qi, W.B.; Karbownik, M.; Calvo, J.R.
Significance of melatonin in antioxidative defense system: reactions and
products. Biol. Signals Recept. 2000, 9, 137–159 [107].
310
100
Davidse, L.C.; Flach, W. Differential binding of methyl benzimidazol-2-yl
carbamate to fungal tubulin as a mechanism of resistance to this antimitotic
agent in mutant strains of Aspergillus nidulans. J. Cell Biol. 1977, 72, 174–193 [108].
309
The first paper, with 1623 citations, presented a narrative review which included melatonin in
the response to oxidative [9]. This was also the first article in the ranking based on the annual citation
rate (ACR), i.e., the ratio between the number of citations of a paper and the number of years since its
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publication: Valko et al. collected 1490 citations in 10 years with an ACR of 162.3 (Table 2). The ACR
classification also highlighted the work by Galano and colleagues [80] which recorded a very high
ACR (=99.7), because their paper, just published in 2011, collected 356 citations.
Table 2. Top 10 articles according to their annual citation rate (ACR, citations/year).
Ranking Article ACR
1 Valko, M.; Morris, H.; Cronin, M.T. D. Metals, toxicity and oxidative stress. Curr. Med.Chem. 2005, 12, 1161–1208 [9]. 162.3
2 Galano, A.; Tan, D.X.; Reiter, R.J. Melatonin as a natural ally against oxidative stress: Aphysicochemical examination. J. Pineal Res. 2011, 51, 1–16 [80]. 99.7
3
Tan, D.-X.; Manchester, L.C.; Terron, M.P.; Flores, L.J.; Reiter, R.J. One molecule, many
derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen
species? J. Pineal Res. 2007, 42, 28–42 [22].
95.6
4 Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress, and antioxidants: Areview. J. Biochem. Mol. Toxicol. 2003, 17, 24–38 [14]. 81.25
5
Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolín, I.; Herrera, F.; Martín, V.; Reiter, R.J.
Regulation of antioxidant enzymes: A significant role for melatonin. J. Pineal Res. 2004, 36,
1–9 [15].
80.5
6 Reiter, R.J. Pineal melatonin: Cell biology of its synthesis and of its physiologicalinteractions. Endocr. Rev. 1991, 12, 151–180 [10]. 65.5
7 Tan, D.-X.; Chen, L.D.; Poeggeler, B.; Manchester, L.C.; Reiter, R.J.; others. Melatonin: Apotent, endogenous hydroxyl radical scavenger. Endocr. J. 1993, 1, 57–60 [11]. 64.5
8 Ancoli-Israel, S.; Cole, R.; Alessi, C.; Chambers, M.; Moorcroft, W.; Pollak, C.P. The role ofactigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26, 342–392 [21]. 64.0
9
Prokopenko, I.; Langenberg, C.; Florez, J.C.; Saxena, R.; Soranzo, N.; Thorleifsson, G.; Loos,
R.J.F.; Manning, A.K.; Jackson, A.U.; Aulchenko, Y.; Potter, S.C.; et al. Variants in MTNR1B
influence fasting glucose levels. Nat. Genet. 2009, 41, 77–81 [89].
57.6
10
Toh, K.L.; Jones, C.R.; He, Y.; Eide, E.J.; Hinz, W.A.; Virshup, D.M.; Ptácek, L.J.; Fu, Y.H. An
hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science
2001, 291, 1040–1043 [23].
51.1
In second place of the top 100 list rank one could find another narrative review by Reiter and
colleagues, published in 1991 [10]. The work entitled “Melatonin: a potent, endogenous hydroxyl radical
scavenger”, with 1420 citations, completed the podium [109]: This was an original article, published by
Tan et al., in 1993. The fourth paper , with 1,219 citations [109] was a narrative review published by
Reiter et al., in 1980. The top 5 ranking concluded with a paper by Lewy and colleagues published in
Science in 1980, with 1105 citations [13].
Unexpectedly, scientific works with limited evidence were cited the most. For the most part,
indeed, articles were narrative reviews/expert opinions (33%), followed by basic research/descriptive
studies (25%), whilst the less represented papers were systematic reviews (23%) and clinical trials
(19%) (Figure 1).
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J. Bioch m. Mol. Toxicol. 2003, 17, 24–38 [14]. 81.25 
5 
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Because reviews are usually more frequently cited, two different top 10 rankings were created to
minimize this bias, in order to evaluate in details the number of citations for reviews vs. original articles
(Tables 3 and 4). We included one letter to the editor among the original articles [35], since it reported a
novel non-extraction radioimmunoassay (RIA) to detect melatonin in plasma. Interestingly, in both the
classifications, melatonin as antioxidant agent and its role in physiology, mainly in regulating mammal
reproduction, were the most cited topics.
Table 3. The top 10 most cited reviews.
Ranking Article Citations
1 Valko, M.; Morris, H.; Cronin, M.T. D. Metals, toxicity and oxidative stress. Curr. Med. Chem.2005, 12, 1161–1208 [9]. 1623
2 Reiter, R.J. Pineal melatonin: Cell biology of its synthesis and of its physiological interactions.Endocr. Rev. 1991, 12, 151–180 [10]. 1572
3 Reiter, R.J. The pineal and its hormones in the control of reproduction in mammals. Endocr. Rev.1980, 1, 109–131 [12]. 1219
4 Maritim, A.C.; Sanders, R.A.; Watkins, J.B. Diabetes, oxidative stress, and antioxidants: Areview. J. Biochem. Mol. Toxicol. 2003, 17, 24–38 [14]. 975
5 Rodriguez, C.; Mayo, J.C.; Sainz, R.M.; Antolín, I.; Herrera, F.; Martín, V.; Reiter, R.J. Regulationof antioxidant enzymes: A significant role for melatonin. J. Pineal Res. 2004, 36, 1–9 [15]. 886
6 Lerner A.B.; Case, J.D.; Takahashi, Y.; Lee, T.; Mori, W. Isolation of melatonin, the pineal glandfactor that lightens melanocytes. J. Am. Chem. Soc. 1958, 80, 2587–2587 [16]. 836
7 Axelrod, J. The pineal gland: A neurochemical transducer. Science 1974, 184, 1341–1348 [17]. 815
8 Brzezinski, A. Melatonin in humans. N. Engl. J. Med. 1997, 336, 186–195 [18]. 802
9 Ancoli-Israel, S.; Cole, R.; Alessi, C.; Chambers, M.; Moorcroft, W.; Pollak, C.P. The role ofactigraphy in the study of sleep and circadian rhythms. Sleep 2003, 26, 342–392 [21]. 768
10 Klein, D.C.; Weller, J.L. Indole metabolism in the pineal gland: A circadian rhythm inN-acetyltransferase. Science 1970, 169, 1093–1095 [20]. 757
Table 4. The top 10 most cited original articles.
Ranking Article Citations
1 Tan, D.-X.; Chen, L.D.; Poeggeler, B.; Manchester, L.C.; Reiter, R.J.; others. Melatonin: A potent,endogenous hydroxyl radical scavenger. Endocr J 1993, 1, 57–60 [11]. 1420
2 Lewy, A.J.; Wehr, T.A.; Goodwin, F.K.; Newsome, D.A.; Markey, S.P. Light suppresses melatoninsecretion in humans. Science 1980, 210, 1267–1269 [13]. 1105
3
Reppert, S.M.; Weaver, D.R.; Ebisawa, T. Cloning and characterization of a mammalian




Toh, K.L.; Jones, C.R.; He, Y.; Eide, E.J.; Hinz, W.A.; Virshup, D.M.; Ptácek, L.J.; Fu, Y.H. An
hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001,
291, 1040–1043 [23].
716
5 Rollag, M.D.; Niswender, G.D. Radioimmunoassay of serum concentrations of melatonin insheep exposed to different lighting regimens. Endocrinology 1976, 98, 482–489 [24]. 688
6
Reppert, S.M.; Godson, C.; Mahle, C.D.; Weaver, D.R.; Slaugenhaupt, S.A.; Gusella, J.F.
Molecular characterization of a second melatonin receptor expressed in human retina and
brain: The Mel1b melatonin receptor. Proc. Natl. Acad. Sci. USA 1995, 92, 8734–8738 [30].
641
7 Fraser, S.; Cowen, P.; Franklin, M.; Franey, C.; Arendt, J. Direct radioimmunoassay formelatonin in plasma. Clin. Chem. 1983, 29, 396–397 [35]. 554
8 Cao, G.; Prior, R.L. Comparison of different analytical methods for assessing total antioxidantcapacity of human serum. Clin. Chem. 1998, 44, 1309–1315 [38]. 516
9 Provencio, I.; Rodriguez, I.R.; Jiang, G.; Hayes, W.P.; Moreira, E.F.; Rollag, M.D. A novel humanopsin in the inner retina. J. Neurosci. Off. J. Soc. Neurosci. 2000, 20, 600–605 [39]. 514
10
Schernhammer, E.S.; Laden, F.; Speizer, F.E.; Willett, W.C.; Hunter, D.J.; Kawachi, I.; Colditz,
G.A. Rotating night shifts and risk of breast cancer in women participating in the nurses’ health
study. J. Natl. Cancer Inst. 2001, 93, 1563–1568 [40].
514
The golden age for melatonin research, accounting for the largest number of “most-cited”
publications, was the 1990–1999 decade, with 35 articles (Figure 2a). This decade also showed the
highest number of total citations (18,604, Figure 2b). The 2000s followed with 31 papers and 16,182
total citations. The highest mean of the number of citations, calculated as the total citations from
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the total number of top-100 articles per decade, was, instead, recorded for the decade of the 1950s,
with 578 mean citations (Figure 2b).








Figure 2. Years of publication (a) of the top 100 most cited articles in the field of melatonin research. 
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The top 100 most cited articles were published in 52 different journals (Table 5). The journal with 
the largest number of papers was Science, with 13 articles, four of them within the first 20. It was 
followed by the Journal of Pineal Research and Endocrinology, with eight and five papers, respectively. 
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The top 100 most cited articles were published in 52 different journals (Table 5). The journal with
the largest number of papers was Science, with 13 articles, four of them within the first 20. It was
followed by the Journal of Pineal Research and Endocrinology, with eight and five papers, respectively.
Table 5. Ranking of the journals with articles within the top 100 list.
Ranking Journal No Articles
1 Science (33.611) 13
2 Journal of Pineal Research (9.600) 8
3 Endocrinology (4.503) 5
4 Proceedings of the National Academy of Sciences USA (9.674) 4
5 Endocrine Reviews (21.059) 3
6 Journal of Neuroscience (6.344) 3
7 Journal of the National Cancer Institute (12.583) 3
8 Nature (41.456) 3
9 Recent Progress in Hormone Research 3
10 Clinical Chemistry (7.911) 2
11 FASEB Journal (5.043) 2
12 Journal of Biological Rhythms (4.573) 2
13 Journal of Physiology - London (5.037) 2
14 Journal of the American Chemical Society (12.113) 2
15 Life Sciences (2.702) 2
16 Neurochemistry International (3.092) 2
17 Neuron (15.054) 2
18 Physiological Reviews (27.324) 2
19 The Journal of Biological Chemistry (4.573) 2
20 The New England Journal of Medicine (55.873) 2
21 Trends in Pharmacological Sciences (11.539) 2
22 Aquaculture (1.878) 1
23 Alternative Medicine Review (3.833) 1
24 Biochemical Pharmacology (5.009) 1
25 Biological Signals and Receptors (2.000) 1
26 Brain Research (2.843) 1
27 Cancer Research (9.329) 1
28 Cell (32.242) 1
29 Cell Biochemistry and Biophysics (1.680) 1
30 Chronobiology International (3.343) 1
31 Current Medicinal Chemistry (3.853) 1
32 Current Topics in Medicinal Chemistry (3.402) 1
33 Digestive Diseases and Sciences (2.613) 1
34 Endocrine Journal (1.997) 1
35 Experientia (5.808) 1
36 FEBS Journal (4.001) 1
37 International Journal of Biochemistry and Cell Biology (4.046) 1
38 Journal of Biochemistry and Molecular Toxicology (1.925) 1
39 Journal of Biomedical Science (2.763) 1
40 Journal of Clinical Psychiatry (5.498) 1
41 Journal of Comparative Physiology (2.036) 1
42 Journal of Neuroimmunology (2.467) 1
43 Nature Genetics (29.352) 1
44 Pharmacological Reviews (17.099) 1
45 Progress in Neurobiology (9.992) 1
46 Quarterly Review of Biology (4.889) 1
47 Sleep (4.591) 1
48 The Journal of Cell Biology (9.834) 1
49 The Lancet (45.217) 1
50 Toxicology (3.621) 1
51 Trends in Immunology (10.399) 1
52 Trends in Neurosciences (13.555) 1
Total 100
Surprisingly, no correlation could be observed between the number of citations in this ranking
and the impact factors of the journals where papers were published (linear regression: R2 = 0.0021,
Figure 3).
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The authors with the highest number of articles within the rank were Reiter with 16 papers (first
author in nine of them), followed by Tan with nine papers (four as first author) and Reppert with six
articles (five as first author) (Table 6). At fourth place, Weaver had five papers and was first Author in
one of them. At fifth place, Axelrod, Nobel Prize in Physiology or Medicine in 1970, had five article
and he was first author in two of them. Axelrod was ex equo with Manchester.
Table 6. Top five authors with the most cited papers on melatonin research.
Name First Author Co-Author Last Author Total
1. Reiter, RJ 9 4 3 16
2. Tan, D-X 4 3 2 9
3. Reppert, SM 4 1 5
4. Weaver, DR 1 4 0 5
5. Axelrod, J 2 2 1 5
6. Manchester, LC 0 2 3 5
3. Discussion
Since the first bibliometrics study on melatonin published two decades ago [110], melatonin has
acquired more and more the role of a pleiotropic molecule, regulating each aspect of the biological clock,
from sleep to appetite and reproduction. The gre impact of t is molecule on research is reflec ed by
the highest number of citations corr sponding to the 1990s and 2000s. Accordingly, the most frequent
topics, found in th top-100 ranking, include sleep physiology, reproduction, circadian rhythm , nd
oxidative stress. T ese tre ds w e also reflected by the conten of the first ten most cited papers.
Nonetheless, melatonin research, to dat , c vers a number of additional fi lds, be ides the biomedi al
ones, wh ch are expecte t greatly contribut to the further importanc of this molecule within the
next years. Recently, melatonin has become a relev nt issue in plant and food sci nces [111,112], but
we could not retrieve any sp cific article among the top 100 rank.
Like any o er bibliometric study, our analysis is ot exempt from a number of l mitations. We
are awar that other citation impact measures, not included in our analysis, also exist, such as the
h-index, and also w did n t control for the effects of self-citation. Additionally, in s me cases, the
number of citations cannot quantify the value of a work contribution to the field [113,114], since this
is affected by many bias, mainly temporal on s [115]. Indeed, a paper ten s to ccumulate citations
over time, while recent articles may not have had enough “publication time” to produce high rates in
the citation analysis. Conversely, the number of citations may then fall progressively as the content
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of the paper is absorbed into the current knowledge. Moreover, our methodology was based on the
Web of Knowledge platform, referring to all subscribed databases simultaneously consulted for the
most comprehensive results. The Web of Science, however, does not index all peer-reviewed journals,
thus we might have missed other journals indexed in other databases, such as Scopus. We did not use
Google Scholar for this citation analysis, since despite being useful to cover some social and humanities
sciences, is not accurate for the biomedical area. It has no quality control, searching within the web for
scholarly content and considering, among the others, non peer-reviewed journals, books and academic
theses, as well as non-scientific sites, such as promotional ones. The Google Scholar citation index is,
thus, not considered highly reliable, at times pre-dating the publication it claims to cite and displaying
manifold versions of the same publication, splitting the citation count [116].
4. Materials and Methods
In February 2016, we consulted Science Citation Index Expanded™, a specific online resource to
quantify citations belonging to the Institute for Scientific Information (ISI) Web of Science™ platform [5].
Under “Basic Research” tag, the keyword (“topic”) used for search was “melatonin” and all the results
were sorted using “time cited - highest to lowest”. A second search was then performed under
the “Cited Reference Search” tag, using the word “melatonin” as “cited title”: every record were
checked to identify the most cited ones and matched with the previously obtained list. The number of
citations corresponded to the “Citing Article Counts”, which referred to all databases and all years,
i.e., Web of Science™ Core Collection (1985-present), CABI, CAB Abstracts® (1973-present), Inspec®
(1969-present), KCI-Korean Journal Database (1980-present), MEDLINE® (1950-present), SciELO
Citation Index (1997-present). We deliberately excluded Google Scholar since it is not purposely
intended to retrieve citations in a systematic and controlled way, as Web of Science or Scopus do [116].
The resulting 100 most cited articles were selected and full-text retrieved to verify the coherence with
the topic (melatonin in research). The following data were recorded for each one: ranking based
on the number of citations; number and names of the authors; year of publication; journal in which
published and the corresponding 2013–2014 Journal Citation Report - Science Edition impact factor.
The type of article was recorded (review, basic science or clinical trial) as well as methodological design
(in vitro study, animal study, case-report, case series, narrative review/expert opinion, observational
study, randomized clinical trial, systematic review/meta-analysis). No exclusion criteria were applied.
Meanwhile, to further confirm the citation results, the Scopus™ database was also consulted. For each
article, the annual citation rate (ACR) was calculated as the ratio between the number of citations (C)
and the number of years (Y) since its publication: ACR = C/Y.
5. Conclusions
Within its limitations, this work highlight and confirms the increasing importance of melatonin,
which, in perspective, is expected to significantly regulate the rhythm of future research, with
predictable new trends going to be related to biomedical and nutritional sciences.
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